Lv3
310 积分 2021-09-13 加入
TROP-2–directed antibody–drug conjugates in advanced NSCLC: A systematic review and meta-analysis of efficacy, safety, and reconstructed survival outcomes
1小时前
待确认
TROP-2–directed antibody–drug conjugates in advanced NSCLC: A systematic review and meta-analysis of efficacy, safety, and reconstructed survival outcomes
1小时前
已完结
1292P Two single-arm, multicenter phase-II trials of PD-1 inhibitors in patients with pulmonary sarcomatoid carcinoma (NCCH1603/NCCH1703)
4个月前
已完结
Efficacy of First-Line Chemotherapy in Patients with Advanced Lung Sarcomatoid Carcinoma
4个月前
已完结
Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma
4个月前
已完结
1292P Two single-arm, multicenter phase-II trials of PD-1 inhibitors in patients with pulmonary sarcomatoid carcinoma (NCCH1603/NCCH1703)
4个月前
已关闭
The efficacy and safety analysis of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma
4个月前
已完结
Efficacy of Zenocutuzumab in NRG1 Fusion–Positive Cancer
5个月前
已完结
皖公网安备34019202002308
